Congenital rubella syndrome secondary prevention
|
Congenital Rubella Syndrome Microchapters |
|
Differentiating Congenital Rubella Syndrome from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Congenital rubella syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Congenital rubella syndrome secondary prevention |
|
Congenital rubella syndrome secondary prevention in the news |
|
Directions to Hospitals Treating Congenital rubella syndrome |
|
Risk calculators and risk factors for Congenital rubella syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
Infants with congenital rubella syndrome should be placed in isolation during their hospital stay. In addition, appropriate measures should be taken to ensure that all healthcare workers and caregivers of the infected child are immune to rubella.[1]
Secondary Prevention
Once an infant has been diagnosed with congenital rubella syndrome, the following precautionary measures should be taken into account:[1]
- During the duration of the hospital stay, the infant should be isolated (i.e.: droplet and contact isolation)
- All hospital contacts and caregivers of infant with congenital rubella syndrome should be ensured that they are immune to rubella virus
- Because infants with congenital rubella syndrome are infectious for at least a period of 12 months, they may pose a risk for unimmunized children and pregnant women
- Seronegative women should be offered the MMR vaccine in the postpartum period to reduce the risk of rubella infection and congenital rubella syndrome in subsequent pregnancies.[2]
References
- ↑ 1.0 1.1 Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html. Accessed on Jan 17, 2017
- ↑ Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L (1998). "Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR Recomm Rep. 47 (RR-8): 1–57. PMID 9639369.